Your browser doesn't support javascript.
loading
Conditional survival and the prognostic value of serum carcinoembryonic antigen level in oldest old with colorectal cancer.
He, Weijing; Yang, Yufei; Liu, Qi; Luo, Dakui; Li, Qingguo; Li, Xinxiang.
  • He W; Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Xuhui District, #270 Dongan' Road, Shanghai, 200032, China.
  • Yang Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Liu Q; Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Xuhui District, #270 Dongan' Road, Shanghai, 200032, China.
  • Luo D; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Li Q; Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Xuhui District, #270 Dongan' Road, Shanghai, 200032, China.
  • Li X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
BMC Gastroenterol ; 24(1): 220, 2024 Jul 10.
Article en En | MEDLINE | ID: mdl-38987680
ABSTRACT

BACKGROUND:

To evaluate the clinical value of serum CEA levels and their implications on the diagnostic value of the conventional TNM staging system in the oldest-old patients with colorectal cancer (CRC).

METHODS:

The recruited subjects were colorectal cancer patients aged 85 and older. The cutoff value for normal CEA level is 5 ng/mL. Patients with elevated CEA levels were categorized as stage C1, and those with normal CEA levels as stage C0. A number of Cox proportional hazard regression models were established to evaluate the prognosis of different prognostic factors with hazard ratios (HRs) and 95% confidence intervals (CIs). The Kaplan-Meier method was utilized to display the disparate prognostic impact of multiple clinicopathological factors with the log-rank test.

RESULTS:

A total of 17,359 oldest-old patients diagnosed with CRC were recruited from the SEER database. The conditional survival of oldest-old patients with CRC was dismal with a 1-year conditional survival of only 11%, 18%, and 30% for patients surviving 1, 3, and 5 years, respectively. Patients with stage C1 exhibited a 48.5% increased risk of CRC-specific mortality compared with stage C0 (HR = 1.485, 95%CI = 1.393-1.583, using stage C0 patients as the reference, P < 0.001). All the stage C0 patients indicated lower HRs relative to the corresponding stage C1 patients.

CONCLUSIONS:

Dismal conditional survival of oldest-old patients with CRC should be given additional consideration. C stage influences the prognosis of oldest-old patients with CRC.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Antígeno Carcinoembrionario / Modelos de Riesgos Proporcionales / Estadificación de Neoplasias Límite: Aged80 / Female / Humans / Male Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Antígeno Carcinoembrionario / Modelos de Riesgos Proporcionales / Estadificación de Neoplasias Límite: Aged80 / Female / Humans / Male Idioma: En Año: 2024 Tipo del documento: Article